Latest News

March 23, 2018 | Clinical Care and InnovationNursing 

Undergoing chemo conveniently at home

Multiple myeloma patients enjoy convenience and comfort, thanks to new home-based chemotherapy service.

March 22, 2018 | Research 

Antibiotic cocktails to fight infections resistant to drugs

SGH team combines 'older' antibiotics with other drugs in bid to tackle such infections.

March 14, 2018 | Clinical Care and InnovationUpclose 

At Life’s End

Mr Tan was referred to the palliative medicine division on Thursday, just one day before the tea ceremony, because his advanced cancer was rapidly progressing. He had one last wish: to attend his daughter’s wedding and give a father’s blessing to the newlyweds.

March 13, 2018 | UpcloseResearch 

Network started by Duke NUS Prof gives female researchers a career boost

While there are more women in science and engineering than ever, the fields remain largely male-dominated, especially at the top. Two women are addressing this with initiatives aimed at giving their fellow women a career boost.

March 09, 2018 | Research 

New insight into diabetic eye disease finds that Indian Singaporeans more prone to vision loss

SNEC & SERI study: Indian Singaporeans have higher chance of developing eye disease

March 06, 2018 | Safety & QualityClinical Care and Innovation 

No more overnight stay before surgery

A team in SGH is driving up the usage of Same Day Admission for surgeries, which has been proven to improve operating theatre timeliness, alleviate bed crunch, reduce patients’ bill size and cut the risk of infections.

March 06, 2018 | Research 

Lab-grown liver tumours help singapore scientists to develop anti-cancer drugs

NCCS, NUS, the Cancer Science Institute of Singapore, the Institute of Bioengineering and Nanotechnology, and A*Star are collaborating to grow mini liver cancer tumours in a lab in hope of developing better treatments.

March 02, 2018 | Research 

Gene mutation helps some cancer patients live longer

NCCS study finds some head and neck cancer patients responding well to a lung cancer drug.